Head-to-head · WeighScore
Fitish vs Tru2u
By GLP-1 ScorecardUpdated
Score comparison
Tru2u has the higher recorded score — 64.4/100 to 60.9/100.
Tru2u grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Tru2u is a US direct-to-consumer telehealth and wellness store offering provider-guided compounded GLP-1 weight-loss therapy alongside hair, skincare, and supplement lines.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Fitish | Tru2u |
|---|---|---|
| WeighScore | 60.9/100 | 64.4/100 |
| Grade | C | C |
| Site position | #349 | #266 |
| Semaglutide | $219/mo (compounded) | $225/mo |
| Tirzepatide | $339/mo (compounded) | $345/mo |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Site position #349 · C
FDAWarning letter issued to FITISH in June 2026. See the FDA warning-letter database.
Strengths
- LegitScript certified
- Ships to all US states
- Price includes consult, shipping, and medication
- Injectable and oral tablet formats
- Microdosing option available
What to consider
- No physical address disclosed
- Broader wellness/beauty brand — GLP-1 is one product line
- Compounded only — no brand-name options
- FDA issued FITISH a warning letter in June 2026; the letter is public in FDA's warning-letter database
Site position #266 · C
Strengths
- Offers compounded semaglutide and tirzepatide plus a combined GLP Squared injection
- Both injectable and oral GLP-1 tablet options available
- Transparent upfront monthly pricing with free shipping
What to consider
- No compounding pharmacy publicly named and no LegitScript seal shown
- Tirzepatide at 345 dollars per month is higher than many compounded competitors
- States served are not published; site states US-only availability
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.